B regulatory cells are indeed present in PDA, and the use of an inhibitor of the Bruton tyrosine kinase, which promotes the differentiation of regulatory B cells, has displayed promising results in terms of PanIN lesions reduction and of IFN‐γ‐CD8+ T cells influx into the tumour. The gene discussed is IFNG; the disease is Patent ductus arteriosus.